nevirapine has been researched along with Kidney Diseases in 6 studies
Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We report the case of a pregnant human immunodeficiency virus type 1-infected woman who developed drug rash with eosinophilia and systemic symptoms syndrome and renal failure shortly after initiation of a nevirapine-containing antiretroviral regimen at 27 weeks' gestation." | 7.72 | Drug rash with eosinophilia and systemic symptoms syndrome and renal toxicity with a nevirapine-containing regimen in a pregnant patient with human immunodeficiency virus. ( Boswell, H; Fan-Havard, P; Knudtson, E; Para, M, 2003) |
| " We report the case of a pregnant human immunodeficiency virus type 1-infected woman who developed drug rash with eosinophilia and systemic symptoms syndrome and renal failure shortly after initiation of a nevirapine-containing antiretroviral regimen at 27 weeks' gestation." | 3.72 | Drug rash with eosinophilia and systemic symptoms syndrome and renal toxicity with a nevirapine-containing regimen in a pregnant patient with human immunodeficiency virus. ( Boswell, H; Fan-Havard, P; Knudtson, E; Para, M, 2003) |
| " These data have now provided a clear and clinically relevant understanding of the individual profiles of drugs within the nucleoside analogue reverse transcriptase inhibitor , HIV protease inhibitor and non-nucleoside analogue reverse transcriptase inhibitor drug classes, and have provided a rational basis for assessing and monitoring these adverse effects in clinical practice." | 2.43 | Adverse effects of antiretroviral therapy for HIV infection: a review of selected topics. ( Mallal, S; Nolan, D; Reiss, P, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mwafongo, A | 1 |
| Nkanaunena, K | 1 |
| Zheng, Y | 1 |
| Hogg, E | 1 |
| Samaneka, W | 1 |
| Mulenga, L | 1 |
| Siika, A | 1 |
| Currier, J | 1 |
| Lockman, S | 1 |
| Hughes, MD | 1 |
| Hosseinipour, M | 1 |
| Nsagha, DS | 1 |
| Pokam, BT | 1 |
| Assob, JC | 1 |
| Njunda, AL | 1 |
| Kibu, OD | 1 |
| Tanue, EA | 1 |
| Ayima, CW | 1 |
| Weledji, PE | 1 |
| Likanonsakul, S | 1 |
| Suntisuklappon, B | 1 |
| Nitiyanontakij, R | 1 |
| Prasithsirikul, W | 1 |
| Nakayama, EE | 1 |
| Shioda, T | 1 |
| Sangsajja, C | 1 |
| Stöhr, W | 1 |
| Reid, A | 1 |
| Walker, AS | 1 |
| Ssali, F | 1 |
| Munderi, P | 1 |
| Mambule, I | 1 |
| Kityo, C | 1 |
| Grosskurth, H | 1 |
| Gilks, CF | 1 |
| Gibb, DM | 1 |
| Hakim, J | 1 |
| Knudtson, E | 1 |
| Para, M | 1 |
| Boswell, H | 1 |
| Fan-Havard, P | 1 |
| Nolan, D | 1 |
| Reiss, P | 1 |
| Mallal, S | 1 |
1 review available for nevirapine and Kidney Diseases
| Article | Year |
|---|---|
Adverse effects of antiretroviral therapy for HIV infection: a review of selected topics.
Topics: Adenine; Alkynes; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cardi | 2005 |
2 trials available for nevirapine and Kidney Diseases
| Article | Year |
|---|---|
Renal events among women treated with tenofovir/emtricitabine in combination with either lopinavir/ritonavir or nevirapine.
Topics: Adenine; Adult; Antiviral Agents; Creatinine; Deoxycytidine; Drug Therapy, Combination; Emtricitabin | 2014 |
Glomerular dysfunction and associated risk factors over 4-5 years following antiretroviral therapy initiation in Africa.
Topics: Adenine; Adult; Africa; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Creatinine; Did | 2011 |
3 other studies available for nevirapine and Kidney Diseases
| Article | Year |
|---|---|
HAART, DOTS and renal disease of patients co-infected with HIV/AIDS and TB in the South West Region of Cameroon.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Antiretroviral Therapy, Highly Active; Cameroon; Co | 2015 |
A Single-Nucleotide Polymorphism in ABCC4 Is Associated with Tenofovir-Related Beta2-Microglobulinuria in Thai Patients with HIV-1 Infection.
Topics: Adult; Antiretroviral Therapy, Highly Active; Female; Gene Frequency; Gene-Environment Interaction; | 2016 |
Drug rash with eosinophilia and systemic symptoms syndrome and renal toxicity with a nevirapine-containing regimen in a pregnant patient with human immunodeficiency virus.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Chemical and Drug Induced Liver Injur | 2003 |